Question 1

What is Rakovina Therapeutics?

Accepted Answer

Rakovina Therapeutics is a Company.

Question 2

How often does Rakovina Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Rakovina Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jul 15, 2026.

Question 4

When was Rakovina Therapeutics last mentioned in news?

Accepted Answer

Last active on Aug 19, 2026.

Question 5

What is Rakovina Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 5 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Rakovina Therapeutics in global news coverage?

Accepted Answer

Attention score of 0, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Rakovina Therapeutics?

Accepted Answer

Rakovina Therapeutics $1.5M Private Placement (Jul 15, 2026, 6 articles).

Question 8

How did the "Rakovina Therapeutics $1.5M Private Placement" event impact Rakovina Therapeutics?

Accepted Answer

Rakovina Therapeutics is the issuer of the private placement, raising $1.5M to fund its pipeline and operations. The offering provides necessary capital but dilutes existing shareholders.

Question 9

How did the "Rakovina Therapeutics 2026 Annual General Meeting" event impact Rakovina Therapeutics?

Accepted Answer

Held its annual general meeting, elected directors, and approved routine matters. No significant change in outlook.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.